We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+17.67%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$11.3B
AUM Growth
+$1.6B
Cap. Flow
+$186M
Cap. Flow %
1.65%
Top 10 Hldgs %
53.18%
Holding
660
New
44
Increased
183
Reduced
381
Closed
52

Sector Composition

Rank Sector Weight
1 Energy 69.1%
2 Materials 2.16%
3 Healthcare 1.94%
4 Financials 1.94%
5 Technology 1.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIOX
176
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$1.79M 0.02%
17,411
+3,473
+25% +$347K
XLRN
177
DELISTED
Acceleron Pharma
XLRN
$1.78M 0.02%
52,287
+10,569
+25% +$344K
PCRX icon
178
Pacira BioSciences
PCRX
$1.02B
$1.76M 0.02%
52,212
+10,542
+25% +$518K
LCI
179
DELISTED
Lannett Company, Inc.
LCI
$1.72M 0.02%
18,044
+12,688
+237% +$1.09M
HL icon
180
Hecla Mining
HL
$10.2B
$1.71M 0.02%
335,771
+98,092
+41% +$396K
ESS icon
181
Essex Property Trust
ESS
$18.9B
$1.7M 0.02%
7,449
-299
-4% -$66.8K
ASRT
182
DELISTED
Assertio
ASRT
$1.68M 0.01%
1,431
+289
+25% +$316K
AAAP
183
DELISTED
Advanced Accelerator Applications S.A.
AAAP
$1.67M 0.01%
55,178
+11,796
+27% +$375K
ACOR
184
DELISTED
Acorda Therapeutics
ACOR
$1.65M 0.01%
539
+110
+26% +$358K
MCRB icon
185
Seres Therapeutics
MCRB
$49.5M
$1.61M 0.01%
+2,776
New +$1.63M
AMAG
186
DELISTED
AMAG Pharmaceuticals
AMAG
$1.58M 0.01%
65,956
+8,218
+14% +$188K
HALO icon
187
Halozyme
HALO
$9.73B
$1.56M 0.01%
181,353
+38,688
+27% +$382K
PVG
188
DELISTED
PRETIUM RESOURCES INC.
PVG
$1.52M 0.01%
136,173
-366,664
-73% -$2.9M
ACHN
189
DELISTED
Achillion Pharmaceuticals
ACHN
$1.5M 0.01%
191,953
+38,285
+25% +$328K
SCLN
190
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
$1.49M 0.01%
113,701
+11,379
+11% +$149K
KIM icon
191
Kimco Realty
KIM
$17.6B
$1.48M 0.01%
47,146
-1,373
-3% -$39.5K
HST icon
192
Host Hotels & Resorts
HST
$16.9B
$1.45M 0.01%
89,530
+1,313
+1% +$20.7K
KYNB
193
Kyntra Bio
KYNB
$28.6M
$1.44M 0.01%
3,509
+750
+27% +$343K
SUPN icon
194
Supernus Pharmaceuticals
SUPN
$2.7B
$1.41M 0.01%
69,426
+14,407
+26% +$256K
TGE
195
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
$1.39M 0.01%
+61,662
New +$1.33M
SAGE
196
DELISTED
Sage Therapeutics
SAGE
$1.36M 0.01%
45,044
+9,036
+25% +$301K
EXR icon
197
Extra Space Storage
EXR
$31.3B
$1.31M 0.01%
14,154
-327
-2% -$29.5K
FRT icon
198
Federal Realty Investment Trust
FRT
$10.9B
$1.31M 0.01%
7,912
-232
-3% -$36.1K
MGNX icon
199
MacroGenics
MGNX
$236M
$1.31M 0.01%
48,530
+9,942
+26% +$224K
MAC icon
200
Macerich
MAC
$7.33B
$1.25M 0.01%
14,597
-351
-2% -$27.5K

Similar funds

ALPS Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, ALPS Advisors held 660 positions worth $11.3B, up 17% from $9.68B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

ALPS Advisors's Q2 2016 filing shows 44 new, 183 increased, 381 reduced and 52 closed positions. Its largest new stake was NGL Energy Partners: 5,895,930 shares worth $114M. The largest sale was Energy Transfer Partners L.p., an estimated $88.3M.

By sector, the portfolio is most concentrated in Energy at 69% of assets, up from 67% a quarter earlier, followed by Materials and Healthcare.

  • ALPS Advisors's largest Q2 2016 buy was NGL Energy Partners: 5,895,930 shares worth $114M.
  • ALPS Advisors added most to Magellan Midstream Partners, L.P. in Q2 2016, an estimated $132M increase.
  • ALPS Advisors's biggest Q2 2016 reduction was Energy Transfer Partners L.p., cutting an estimated $88.3M.
  • ALPS Advisors fully exited Brookfield in Q2 2016, selling an estimated $48.6M.
  • ALPS Advisors's ten largest holdings make up 53% of its $11.3B portfolio in Q2 2016.
  • ALPS Advisors opened 44 new positions and closed 52 in Q2 2016.
  • ALPS Advisors's portfolio value rose 17% quarter-over-quarter to $11.3B.

Based on ALPS Advisors's 13F filing for Q2 2016, filed 27 Jul 2016.